1303605-20-0Relevant academic research and scientific papers
Synthesis and biological evaluation of125I/123I- labelled analogues of citalopram and escitalopram as potential radioligands for imaging of the serotonin transporter
Madsen, Jacob,Elfving, Betina,Frokjaer, Vibe G.,Kornum, Birgitte R.,Thomsen, Gerda,Martiny, Lars,Knudsen, Gitte M.
, p. 185 - 190 (2011)
Two novel radioligands for the serotonin transporter (SERT), [ 125I]{3-[5-iodo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl] -propyl}-dimethylamine ([125I]-2) and S-[125I]{3-[5-iodo- 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-propyl}-dimethylamine ([ 125I]-(S)-2) were synthesized in a Br/125I exchange reaction. Binding experiments in rats yielded Kd values of 0.7 ± 0.06 and 0.52± 0.02 nM for [125I]-2 and [ 125I]-(S)-2, respectively. One hour after intravenous injection of [125I]-2, 0.34% of the injected dose had accumulated in the brain. The highest hypothalamus-to-cerebellum ratio was reached 2 h after injection of [125I]-(S)-2 and amounted to 2.4. Pre-treatment experiments with paroxetine resulted in effective reduction of the target-to-cerebellum ratios. The corresponding iodine-123 labelled compound S-[123I]{3-[5-Iodo-1- (4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-propyl}-dimethylamine [ 123I]-S-2 was investigated in a pig single photon emission computed tomography (SPECT) study. Between 60 and 110 min after IV injection, the midbrain-to-cerebellum ratio was 1.2. However, the uptake did not differ between high-density and medium-density regions questioning the feasibility of the radioligand in imaging cortical SERT distribution in vivo. These data suggest that the iodine-labelled derivatives of citalopram and escitalopram are not superior to another SPECT tracer for the SERT, namely [123I]ADAM. Copyright
